Established in 2005 from the bone marrow of a 35-year-old Chinese man with AML-M2 after idarubicin/cysteine arabinoside treatment; cells were described to express natural killer cell-related antigens in addition to myeloid ones and to exhibit TP53 gene alteration; cells are tumorigenic in nude and SCID mice
Catalogue number:
CSC-C0628
Size:
1.0 mL
Storage temp:
Frozen with 70% medium, 20% FBS, 10% DMSO at about 12 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen